Melanocyte stimulating hormone
α Melanocyte stimulating hormone (α MSH) modulates human chondrocyte activation induced by proinflammatory cytokines
11
Anti-inflammatory and anti-invasive effects of alpha-melanocyte-stimulating hormone in human melanoma cells
12
The experimental generation of antibodies to alpha melanocyte stimulating hormone and adrenocorticotropic hormone
8
Evaluation of polydentate picolinic acid chelating ligands and an α-melanocyte-stimulating hormone derivative for targeted alpha therapy using ISOL-produced 225Ac
20
The α-melanocyte stimulating hormone/peroxisome proliferator activated receptor-γ pathway down-regulates proliferation in melanoma cell lines
13
Alpha melanocyte stimulating hormone reduces endotoxin induced liver inflammation
8
Preclinical Melanoma Imaging with 68Ga-Labeled α-Melanocyte-Stimulating Hormone Derivatives Using PET
9
Alpha melanocyte stimulating hormone protects against renal injury after ischemia in mice and rats
9
Genetic disruption of γ melanocyte–stimulating hormone signaling leads to salt sensitive hypertension in the mouse
9
Melanoma cell migration is upregulated by tumour necrosis factor-alpha and suppressed by alpha-melanocyte-stimulating hormone
8
α-melanocyte stimulating hormone modulates the central acyl ghrelin-induced stimulation of feeding, gastrointestinal motility, and colonic secretion
10
In vivo multiplex quantitative analysis of 3 forms of alpha melanocyte stimulating hormone in pituitary of prolyl endopeptidase deficient mice
9
The increase of alpha-melanocyte-stimulating hormone in the plasma of chronic fatigue syndrome patients
6
High Polymorphism at the Human Melanocortin 1 Receptor Locus
12
Multiple feedback regulatory loops upon rat hypothalamic corticotropin releasing hormone secretion Potential clinical implications
9
Behavioural and neuroendocrine effects of environmental background colour and social interaction in Arctic charr (Salvelinus alpinus)
9
Modular nanotransporters: a multipurpose in vivo working platform for targeted drug delivery
16
Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles
21
Overcoming Diminished Motivation
131
Equine pituitary pars intermedia dysfunction: current perspectives on diagnosis and management
8